Omda AS (OSL:OMDA)
Norway · Delayed Price · Currency is NOK 49.00
-1.60 (-3.16%)
At close: Oct 3, 2025
Omda AS Revenue
Omda AS had revenue of 121.32M NOK in the quarter ending June 30, 2025, with 16.10% growth. This brings the company's revenue in the last twelve months to 458.96M, up 10.33% year-over-year. In the year 2024, Omda AS had annual revenue of 426.27M with 3.44% growth.
Revenue (ttm)
458.96M
Revenue Growth
+10.33%
P/S Ratio
2.14
Revenue / Employee
1.57M
Employees
268
Market Cap
984.37M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 426.27M | 14.16M | 3.44% |
| Dec 31, 2023 | 412.10M | 43.94M | 11.93% |
| Dec 31, 2022 | 368.17M | 37.65M | 11.39% |
| Dec 31, 2021 | 330.52M | 101.24M | 44.16% |
| Dec 31, 2020 | 229.28M | 22.05M | 10.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 628.08M |
| Nordhealth AS | 578.17M |
| Photocure ASA | 522.86M |
| ArcticZymes Technologies ASA | 104.33M |
| Vistin Pharma ASA | 452.25M |
| Gentian Diagnostics ASA | 163.38M |
| Nykode Therapeutics AS | 79.85M |
| Lytix Biopharma AS | 608.00K |
Omda AS News
- 5 weeks ago - Omda AS (FRA:6Q1) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Milestones - GuruFocus